Taken together, these results suggest PBRM1 depleted ccRCC cells exist in a pro-apoptotic, “primed” state, increasing their susceptibility to cell-death-targeted agents like MCL1 inhibitors. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.